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Abstract
Attempts to improve substance use disorder (SUDs) treatment outcomes have been made
by identifying subgroups of clients with psychoactive comorbidities and tailoring
treatment approaches accordingly. This study sought to determine the prevalence of
Attention-deficit Hyperactivity Disorder (ADHD) among admittees to a 28-day,
residential program. It was hypothesized that ADHD screening and assessment would
result in a higher prevalence rate when compared to the clinical record. It was further
hypothesized that clients with ADHD would have higher, earlier unsuccessful
terminations and higher overall unsuccessful terminations than non-ADHD clients. The
differences in the prevalence rates (3.44% clinical record and 43.68% study psychologist)
were statistically significant (p<.OOI). Analysis of treatment outcomes for the two
groups was not statistically significant.
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Attention-Deficit Hyperactivity Disorder and Substance Use Disorders:
Prevalence and Treatment Outcomes
Substance use disorders (SUD) is a major health problem in the United States.
Traditional substance abuse/dependence treatment modalities have high failure rates. During the
1980s, with the goal of improving treatment outcomes, attempts were made to identifY subgroups
of patients with psychiatric co-morbidities and to tailor treatment approaches to increase positive
treatment outcomes (Gordis, 1987). During this period, the impact of Attention-deficit
Hyperactivity Disorder (ADHD) on addictions treatment was not broadly studied as it was a
generally held belief that ADHD symptoms were resolved by adulthood. As recently as 1996,
Hill & Schoener in their study concluded that the symptoms of ADHD essentially disappear in
adulthood. In a 1989 report, the Institute of Medicine of the U.S. National Academy of Sciences
strongly encouraged researchers to analyze the outcomes of client-treatment interventions.
During the 1990s, researchers began focusing on the prevalence of the comorbidity of ADHD
and SUD in an attempt to link specific treatment modalities to client attributes and to better
understand treatment outcomes.
There is a body of research that supports the validity of adult ADHD. In fact, clinical
correlates of ADHD are similar for children and adults. Downy, Stelson, Pomerleau, & Giodani,
(1997) documented the presence in adults of inattention, impulsivity, and hyperactivity which are
the defining features of ADHD. In a family study of children with ADHD, of the non-referred
adult relatives more than two thirds reported levels of ADHD symptoms within the severe range
(Biederman, Faraone, Keenan, Knee, & Tsuang, 1990). Treatment studies document that the
medications effective in the treatment of pediatric ADHD are equally effective in treating adult
symptoms (Faraone, Biederman, Spencer, Michelson, Adler, eta!. 2005; Kelsey, Sunmer, Casat,
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Coury, Quintana, et al. 2004; Levin, Evans, & Kleber, 1998; Ratey, Greenberg, & Lindem, 1991;
Spencer, Biederman, Wilens, Prince, Hatch, et al. 1998). Both children and adults demonstrate
similar neuropsychological deficits in studies assessing vigilance, executive functions, motoric
inhibitions and verbal learning (Seidman, Biederman, Faraone, Weber, & Ouellette, 1997;
Barkley, Fischer, Edelbrock, & Smallish, 1990).
The prevalence of ADHD in children has been reported at 5% to 10% (Biederman, 1998;
Lambert, Sandoval, & Sassone, 1978; Wender, 1997) with studies reporting persistence of
ADHD into adulthood ranging from 10% to 70% (Barkley, 1990; Levin et al. 1998; Weiss, 1993;
Wender, 1997). Studies of prevalence of adult ADHD also vary in their outcomes. Murphy &
Barkley (1996) reported a 4. 7% prevalence rate while Heiligenstein et al. ( 1998) reported a 4%
rate. Both of these studies had limited generalizability due to study design limitations. Two
rather well-designed studies provided similar results. Faraone, Sergeant, Gill berg, & Biederman
(2003) reported a 3.2% prevalence rate for adults presenting with a full diagnostic picture and
6.6% with a partial symptom picture. Faraone & Biederman (2005) in a study of 966 randomly
selected adults reported a 3% rate for narrowly defined ADHD and 16.4% for a broadly defined
diagnosis. Kessler, Adler, Barkley, Biederman, Conners, et al. (2005) through the National
Comorbidity Survey surveyed 3,199 individuals and used a probability sampling to assure
generalizability. The result was an estimated adult ADHD prevalence rate of 4.4%. It was
reported in this study that adult ADHD was highly associated with other DSM-IV Disorders.
Faraone & Biederman (2005) conclude that "ADHD is one of the common psychiatric disorders
of adulthood."
Carroll & Rounsaville (1993) reported a 35% prevalence rate of ADHD among adult
cocaine abusers seeking treatment. Approximately 50% of adults with ADHD have a history of
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SUD and it was concluded that ADHD was a significant risk factor for the development of a
SUD (Biederman, Wilens, Mick, Milberger, Spencer, et al.l995). A history of childhood ADHD
has been found in 22% to 71% of substance abusing adults (Wilens, Biederman, & Spencer,
1996). In a study of 201 adults seeking drug treatment, Schubener, Tzelepis, Milberger,
Lockhart, Kruger, et al. (2000) observed that nearly one quarter of the individuals entering
inpatient treatment met the DSM-IV criteria for ADHD diagnosis. Studies of adult alcohol
abusers yielded rates of between 35% and 71% of adult alcoholics with childhood-onset and
persistent ADHD (Goodwin, Schulsinger, & Hermansen, 1975; Wilens, Spencer, & Biederman,
1995). Clure, Brady, Saladin, Johnson, Waid, et al. (1999) found that in the 136 subjects who
were in residential treatment for SUD 32% had a diagnosis of ADHD. Johann, Bobbe,
Pritzhammer, & Wodarz, (2003) reported a prevalence rate of 21.3% of ADHD in a sample of
134 adult, alcohol-dependent German subjects. There is a higher rate of ADHD among
substance abusers than the estimated rate in the general population. These and many other
studies support ADHD as a risk factor for the development of SUD. In fact, Giedd (2003)
observed, "a plethora of epidemiologic data indicating that the diagnoses of ADHD and
substance abuse occur together more frequently than expected by chance alone."
Attempts to explain the vulnerability of individuals diagnosed with ADHD to SUD have
been made. Khantzian (1985), as well as Carroll & Rounsaville (1993) suggest that cocaine
abusing clients' abuse patterns are consistent with clinical descriptions of self-medication.
Untreated ADHD is a significant risk factor for SUD (Biederman, Wilens, Mick, Spencer, &
Faraone, 1999). It is acknowledged in the addictions field that low self-worth and poor executive
functioning are associated with alcohol and other drug abuse. Individuals with ADHD,
especially when it is undiagnosed and/or untreated, are vulnerable to drug use and abuse.
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Katusic, Barbaresi, Colligan, Weaver, Leibson, et al. (2005) concluded that psychostimulant
treatment of childhood ADHD was associated with a reduced risk for later substance abuse
among boys with ADHD.
Research supports the need for accurate assessment and treatment of ADHD early in
SUD treatment. Carroll & Rounsaville (1993) found that cocaine abusers with ADHD diagnosed
in childhood did worse in treatment than cocaine users with no history of ADHD even though
they had more treatment exposures. Wise, Cuffe and Fischer (200 I) found that adolescents in
drug treatment with comorbid ADHD did significantly worse than those without ADHD. Levin,
Evans, Vosburg, Horton, Brooks, et al. (2004) found that patients with adult ADHD had the
highest early drop-out rates (35%) in a long-term, therapeutic community program. They also
had lower completion rates. In fact, no one with ADHD in this study graduated from treatment.
Wilens, Biederman, & Mick (1998) reported that participants with adult ADHD in SUD
treatment had slower remission rates and longer duration of SUD when compared with non
ADHD participants with SUD.
It was observed by the treatment staff at the Center for Alcoholism and Drug Addiction

Services (CAD AS), Dayton, OH that a significant number of clients presented for residential
treatment with pronounced symptoms of ADHD without diagnosis. These clients were observed
to be inattentive, impulsive, agitated and restless-to-hyperactive. In small group therapy
sessions, they were observed sub-grouping, playing with objects, involved in a number of
distracting physical behaviors and interrupting/blurting out comments. They often went to
lectures unprepared despite prompts. Staff frequently complained about them impulsively
violating boundaries and rules. When these symptoms were observed, the clients were referred
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to the consultant psychologist and, if a diagnosis of ADHD was made, those clients were referred
to a psychiatrist to determine if they could benefit from a medical treatment.
To explore the observation that a significant number of clients were admitted to treatment
with ADHD, but without a diagnosis, a retrospective review of all charts of all the 2004 clients
assigned to this investigator at CADAS was made. This review revealed that, of the 97 clients
assigned to this investigator, only one had a clinical diagnosis of ADHD at the time of
admission. Thirteen additional clients were observed to have pronounced symptoms of ADHD
and were referred to the consultant psychologist. Prior to assessment for ADHD, eight received
an unsuccessful termination from treatment. The other five were assessed and were diagnosed
with adult ADHD. The prevalence rate of all clients with pronounced symptoms of ADHD was
14%. The unsuccessful discharge rate for those not observed to have pronounced symptoms of
ADHD was 19% while the unsuccessful discharge rate for those with pronounced symptoms was
57%.
The goal of this study was to determine the prevalence of ADHD among admittees to The
Center for Alcoholism and Drug Addiction Services (CAD AS) a 28 day residential treatment
program and to explore treatment outcomes. It was hypothesized that the screening and
subsequent assessment of clients for ADHD would result in a higher prevalence rate when
compared to the prevalence rate of the documented clinical record. In addition, it was
hypothesized that clients diagnosed with ADHD would have higher early unsuccessful
terminations and higher overall unsuccessful terminations than clients who are not diagnosed
withADHD
METHOD

--------------~

------------------------------------------
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Subjects were adults admitted to CAD AS. In order to be eligible for residential
treatment, all admittees had to have, at least, one Axis I SUD diagnosis. All admittees were
assessed and diagnosed at CrisisCare prior to admission. CrisisCare provides all mental health
and substance abuse assessments for Montgomery County, OH residents who do not have
insurance or financial resources to cover a private assessment. All admittees between June 21,
2006 and September 13, 2006 were invited by the study interviewer to participate until the
proposed number of ninety subjects was met. The program was visited twice weekly by the
interviewer. The Monday and Tuesday admittees were interviewed on Wednesdays and the
Wednesday and Thursday admittees were interviewed on Sundays. In addition, admittees were
interviewed by gender in either small groups or individually based upon the number of
admissions.
The Participant Consent Form was read to the potential subjects and some background
information about comorbid SUD and ADHD was provided by the interviewer. After receiving
written agreement to participate, all subjects completed the Adult ADHD Self-Report Scale
(ASRS-vl.l) Symptom Checklist (Kessler, Adler, Ames, Demler, Faraone, eta!. 2005). Adler,
Spencer, Faraone, Kessler, Biederman, eta!. (2006) studied the pilot ASRS and its internal
consistency symptom scores was assessed by Cronbach's Alpha and the result was 0.88. Adler
et a!. (2006) concluded that this scale was reliable and valid. The subjects were instructed to
focus on periods of abstinence or their behaviors prior to the development of the SUD and not on
their substance abuse related behaviors when responding to the ASRS. The subjects subsequently
were interviewed individually to determine whether or not they had been diagnosed with and/or
treated for ADHD as children. The clinical records were reviewed for Axis I and Axis II
diagnoses and to obtain specific demographic information. The subjects whose scores were 17
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23 (likely to have ADHD) or 24 or greater (highly likely to have ADHD) for either Part A
(Inattentive) or Part B (Hyperactive/Impulsive) were referred to the CAD AS consultant
psychologist for an ADHD assessment.
The consultant psychologist was given a list of subjects to be assessed, but not their
scores. Also, he was not given information as to whether or not the subjects had been diagnosed
with ADHD as children. The psychologist knew the subjects were either likely or highly likely to
have ADHD in order to be referred. The consultant psychologist determined that in order to be
diagnosed with ADHD for this study, the participants had to meet the criteria set forth in the
1
Diagnostic and Statistical Manual ofMental Disorders (4 h ed.; DSM-IV; American Psychiatric

Association, 1994). Because symptoms of SUD mimic the ADHD symptoms of impulsivity,
hyperactivity and inattention, the psychologist, during assessment, confirmed that the clients
experienced ADHD symptoms prior to the development of the SUD in order to make a diagnosis
of ADHD. It was decided by the psychologist and this investigator that those clients who had
certain psychiatric conditions (e.g. anxiety disorders and Bipolar Disorder with either manic or
hypomanic features) as diagnosed either by the psychologist or Crisis Care, would not be
diagnosed ADHD due to the potential confounding variables and symptoms-overlap associated
with those conditions. The psychologist assessed the Monday/Tuesday admittees their first
weekend in treatment and the Wednesday/Thursday admittees were assessed their second
weekend in treatment.
All subjects' treatment outcomes were documented as either successful or unsuccessful.
Successful discharges included those individuals who completed the 28-day program and
graduated. Unsuccessful discharges for the purposes of this study included Administrative (rule
infraction) or Against Staff Advice discharges. One participant had a miscarriage and received a
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Medical discharge on day 26 of treatment and another client's medical problems resulted in a
medical discharge on day six. These unsuccessful discharges were treated separately from the
other unsuccessful discharges in this study as they did not appear to be related to having or not
having a diagnosis of ADHD. Three admittees refused to participate, three left treatment prior to
being approached to participate and one admittee agreed to participate, but was not included
because of the special challenge to diagnostic accuracy posed by the presence of a severe hearing
impairment. Three subjects were interviewed, screened and determined appropriate for referral
to the psychologist, but had an unsuccessful discharge before they could be assessed. One
subject was referred to the psychologist even though he did not meet the criteria (likely or highly
likely) for referral because he had been diagnosed and treated as a child for ADHD. Inter-rater
reliability was not an issue as there was one interviewer and one psychologist involved in this
study. The interviewer had a Masters in Rehabilitation Counseling. The psychologist was
licensed by the State of Ohio. Prior to initiating this study, human subjects approval was sought
and granted by the Wright State University (WSU) Institutional Review Board (IRB).
RESULTS
In the study proposal, it was determined that the investigator would approach new
admissions until an N=90 was reached. Subsequent to being granted approval by the IRB of
WSU and before reaching N=90, 97 clients were admitted to residential treatment. Three
admittees left before being approached by the investigator, three refused to participate and one
was not included because of a hearing impairment. Three admittees left treatment after agreeing
to participate, being screened and receiving a referral to the psychologist, but before being
assessed. This resulted in an N=87. Two participants were screened, referred, assessed, not
diagnosed with ADHD and received medical discharges (one client had a miscarriage and one
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needed gallbladder surgery). Neither of these medical discharges appeared to be related to
ADHD so to avoid any potential confounding, they were excluded from the data used to evaluate
the second hypothesis. As a result, N=85 for the second hypothesis. Because of time limitations
inherent in this study, the investigator could not approach additional adrnittees for inclusion.
To determine if the "convenience" sample demographics (Table I) was representative of
the CAD AS residential population, the demographic data collected were compared with the same
demographic information from the 2005 population of CAD AS residential clients (Table II).
This "convenience" sample demographics when compared with the "population" of CADAS
residential clients do not appear to be significantly different. Even though there was no random
assignment of participants, this sample appears to be representative of the CAD AS population.
Among the 87 participants, three (3) were admitted with a diagnosis of ADHD in the
clinical record. The prevalence rate from the clinical records was 3%. The prevalence rate from
the psychologist's assessments was 44% (Table III). Because the three participants admitted
with a diagnosis of ADHD were re-assessed and subsequently re-diagnosed with ADHD a
McNemar's test (Fleiss, 1981) was utilized to obtain a chi-square value of33 p<.OOI. The
differences in the two prevalence rates were statistically significant. In the McNemar's test only
the pairs in which the numbers differ in the antecedent factor contribute to the test statistic.
The second hypothesis was that the participants with ADHD would have higher, early
unsuccessful terminations and higher overall, unsuccessful terminations than clients not
diagnosed with ADHD. The ADHD group had a slightly lower mean number of days in
treatment (24.92 days) than the non-ADHD group (26.11 days). An analysis of variance
revealed that the difference between groups was not significant (p=.325). In addition, an
analysis of treatment success for the two groups was not statistically significant.
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Although not included in this study as a formal hypothesis, an analysis was applied to the
ASRS scores to examine its ability to predict the diagnosis of ADHD in this study. Since the
ASRS scores are continuous and the diagnosis (yes/no) is not, a point bi-serial correlation
statistic was used. The ASRS was a good predictor of an ADHD diagnosis. ASRS Part A and
ADHD diagnosis, r = .656, N = 87,p<.05 and ASRS Part Band ADHD diagnosis, r = .615, N =
87, p<.05. In terms of prediction for either part, higher scores tend to predict an ADHD
diagnosis. Part A was only slightly better at predicting ADHD.
DISCUSSION
Knowledge of the prevalence of adult ADHD plays an important role for clinical practice.
If a disorder is thought to be rare, clinicians may be reluctant to make a diagnosis. Conversely, if
a disorder is viewed as common, clinicians will screen for it and be more attentive to the
symptoms when assessing clients/patients' complaints. In children, screening for ADHD is
relatively routine as it has been viewed as a common childhood disorder. In adults, screening for
ADHD is relatively uncommon. Kessler, et al. (2006) reported that in the 12 months prior to
being interviewed for their survey 53.1% of the women and 36.5% of the men with adult ADHD
had received either mental health or substance-related treatment. Only 10.9% of these
participants had received treatment for adult ADHD. This is a major concern as adult ADHD
alone produces serious impairments in a wide-range of major life areas.
In this study, the psychologist diagnosed 44% of the 87 participants with adult ADHD.
Although this prevalence rate falls on the high end, this prevalence rate falls within the range
reported by other studies. Of note, prior to implementing the study design, the psychologist and
this investigator discussed taking a "conservative" approach to the diagnosis of ADHD. Some
clinical researchers have suggested that the symptoms of adult ADHD are more varied and less
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severe in adults and need to be taken into account during assessment (Faraone & Biederman,
2005) or have suggested a reduction in the DSM-IV requirement for six of nine symptoms
(Ratey, Greenberg, Bemporad, & Lindem, 1992). Neither of these suggestions was implemented
in this study.
Previous studies, as noted, indicated that the prognosis of subjects with SUD is
negatively affected by the comorbid presence of ADHD. As reported above, a retrospective
review of 97 CADAS client charts revealed that clients with pronounced traits of ADHD had a
57% unsuccessful discharge rate while those clients who did not have pronounced symptoms had
a 19% unsuccessful discharge rate. This outcome was the basis of the second hypothesis.
Although not related to either study hypotheses, valuable information was gained from
the study interviews. During the interviews, all subjects who had a Cocaine Abuse or Cocaine
Dependence diagnosis were asked questions about how cocaine affected them. None of the
subjects who scored below 17 (the referral score cut-off score) reported paradoxical effects of
cocaine. Of the 31 with a history of cocaine use who were referred to the psychologist, 22
reported paradoxical effects. Subjects, when making comments about their experience using
cocaine, made statements like, "I think better and I am more organized" or ''I'm mellow. I'm just
more relaxed. It is kind of weird." In fact, one subject stated, "I call crack my medicine."
Subjects, who reported this effect, clearly recognized that they were different from other crack
cocaine users, yet seemed somewhat surprised to look at this effect in the context of ADHD. It
seemed to this investigator that almost immediately they were making sense of an experience
that they had not previously examined. Although this study (Table IV) and other research
studies do not find a difference between ADHD and non-ADHD patterns of specific drug use
(Biederman, eta!. 1995; Clure, et al.l999; Levin, et al.l998; Schubiner, eta!. 2000), this study

ADHD&SUD

14

outcome does offer some support to Carroll & Rounsaville (1993) and Khantzian (1985) self
medication hypothesis.
Of the 3 8 subjects who were referred to the psychologist, only 7 reported a childhood
diagnosis of ADHD. Even though ADHD is regularly screened in childhood, it is evident that it
is still being missed. The clients of CAD AS residential often come from homes that are chaotic
as many come from situations where either one or both of their parents suffer from SUD. As
previously noted in this paper, untreated ADHD is a risk factor for SUD and treated ADHD
reduces the risk
When treatment for comorbid ADHD is incorporated into SUD treatment, it has been
found that treatment outcomes improve for these clients (Cocores, eta!. 1987; Wender, 1998).
This supports my clinical observations. In this study, the prevalence rate of comorbid ADHD in
the clinical record was 3% and the prevalence rate from the psychologist's assessments was
44%. The diagnosis of ADHD may have been missed at the initial assessment for a number of

reasons. The inattentiveness or restlessness of the clients during the assessment may have been
confused with withdrawal symptoms. Adults, who have better executive functioning than
children, may be better able to manage the ADHD symptoms in a one to two hour assessment
where the client is the single focus of attention. Until recently, ADHD has been considered a
childhood disorder and may be routinely overlooked by tl1ose completing the assessments. In
this study, the Adult ADHD Self-Report Scale (ASRS) was a good predictor of an ADHD
diagnosis; it is easily administered and scored. To minimize under-diagnosis, it could be
incorporated into the assessment processes.

Clinical Observations and Concerns. The symptoms of comorbid ADHD and SUD
overlap and those symptoms are observed as egregious when a client is admitted into residential
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treatment. Often during the first individual session, I recognized that the observed impulsivity,
agitation and inattention were beyond what I would normally encounter in a client with only a
SUD. Research supports that adults in SUD treatment with comorbid ADHD have a greater
treatment failure rate and higher relapse rate than clients without ADHD (Carroll & Rounsaville,
1993; Cocores, Davies, Mueller, & Gold, 1987; Levin, Evans, & Kleber, 1999). When clients
were quickly able to be diagnosed by the psychologist and subsequently seen by a psychiatrist
who prescribed a medication (typically Bupropion or Atomoxetine), significant positive changes
in behaviors were observed especially when cognitive-behavioral treatment (CBT) interventions
were also applied. Since that was not always possible because the program is only 28 days long,
I found that alerting the staff to the diagnosis and providing appropriate CBT was helpful.
In addictions treatment, a promise is made that with continued abstinence the clients will
experience manageable lifestyles. Of course, if ADHD is not diagnosed or not treated that
promise, in effect, dooms the clients to failure. Clients with untreated ADHD do not easily create
manageable lifestyles. Consequently, I emphasized this concern to my ADHD diagnosed clients
and made referrals to mental health centers either to start receiving or to continue receiving
medication treatment, as well as individual counseling for ADHD. Of note, I found clients who
were prescribed medication for ADHD repeatedly complained of not liking the way it made them
"feel" and, in exploring this complaint, I found that the clients were uncomfortable with the
physical changes they experienced. Initially, it seemed, they missed the "energy" level they
experienced with the untreated ADHD and wanted to discontinue treatment. I found it productive
to suggest to my clients that this need not be interpreted as problematic, just different and that
they would, with continued use, develop a new comfort level. Bemporad (1998) refers to this
phenomenon and suggests that, in addition to the problems accommodating to the physical
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changes, once the ADHD clients slow down and are able to reflect upon their lives, that they are
faced with an inability to deny their painful pasts.
In addition to the cognitive-behavioral and medication treatment interventions, SUD
clients with comorbid ADHD may benefit from the research that is being conducted in the field
of traumatic brain injuries (TBI). Bates, Bowden, & Barry (2002) suggest that traditional SUD
treatment providers make a shift in their theoretical perspectives by incorporating cognitive
rehabilitation practices developed for individuals with TBI. Damage caused by drug abuse
affects brain centers associated with memory, planning, goal setting and use of environmental
feedback. These executive functions deficits are similar to those experienced by individuals with
ADHD and may offer an explanation as to why the symptoms of comorbid ADHD and SUD are
so egregious. Methods that promote neurocognitive recovery could be of special assistance to
those diagnosed with comorbid ADHD and SUD and need to be explored.

LIMITATIONS
The sample size was a limitation in this study. Figure I shows that while the treatment
outcomes were not significantly different between the ADHD and non-ADHD groups, it is
evident that the negative treatment outcomes for the ADHD group were greater and with a larger
sample size the difference would have most likely been significant. With the length of treatment
at CADAS being 28 days, it was unlikely that the earlier drop-out rate reported by Levin, et al.
(2004) would be supported. Nevertheless, the retrospective review ofthe 2004 clinical files did
indicate this as a possible study outcome.
The treatment design may have had an impact on the outcomes. All participants when
approached to participate in the study were informed of the previous unsuccessful outcomes of
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those clients who had the pronounced symptoms of ADHD and they were informed of the
outcome of their assessment (diagnosed with ADHD or not). It is reasonable to conclude that
armed with this information, the participants may have been more focused on self-management
than otherwise expected. This investigator was repeatedly seen by those participants who had
been screened and assessed when presenting on the unit to approach subsequent admittees.
Frequently, those diagnosed with ADHD would approach this investigator and discuss what they
were learning about managing both of their disorders. In fact, when this investigator walked on
to the residential unit, she was greeted with the armouncement of"here comes the ADHD lady."
Not only the participants were affected by the study design, it is possible that the
counselors and technicians were, too.

The assessment information and diagnosis was

subsequently included in the participants' clinical records. It is possible that awareness of this
comorbid disorder affected the treatment of the clients diagnosed with ADHD by the CADAS
staff. It is likely that, with this knowledge, behaviors that might otherwise have been labeled as
oppositional, defiant or noncompliant were now viewed as symptomatic of ADHD and handled
differently. If these assumptions are accurate, this underscores the need for accurate assessment
of ADI-!D early in treatment.
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Table I Demographic data (N = 85)

ADHD (n=38)

No ADHD (n=47)

Mean Age (cr)

30.50 (9.937)

39.68 (9.087)

Mean Yrs of Ed. (cr)

I 0.71 (1.972)

11.6 (1.93)

Gender: Male

58%

64%

Race:

African-American

18%

38%

White

82%

62%
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Table II Demographic data from 2005 and 2006 samples

2005 Sample (N=444)

2006 Study Sample (n=87)

Mean Age

36.23

35.71

Mean Yrs of Ed.

11.476

11.23

Gender: Male

64.4%

59%

39.9%

31%

White

59%

69%

Other

1.1%

0%

Race:

African-American
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Table III Prevalence rates of ADHD (N=87)

Diagnosis by Psychologist
Total

ADHD

NoADHD

ADHD

3

0

3

NoADHD

35

49

84

Total

38

49

87

Diagnosis from Clinical Records

Note. The prevalence rates were 3.44% and 43.68% from clinical records
and by the study psychologist, respectively. Chi square= 33.0, p<.OOl.
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Table IV Reported substances of use (N = 85)

ADHD (n=38)

No ADHD (n=47)

Total

Alcohol

21

31

52

Amphetamine

2

0

2

Cannabis

28

16

44

Cocaine

27

35

62

Hallucinogen

1

0

1

Opiate

8

4

12

Sedative

8

5

13
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